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Abstract
Objective
The purpose of this study was the assessment of volumetric CT-perfusion (CTP) of the
lower leg musculature in patients with symptomatic peripheral arterial disease (PAD) of
the lower extremities, comparing it with established angiographic and hemodynamic
parameters.
Materials and methods
Thirty-five consecutive patients with symptomatic PAD of the lower extremities requiring
interventional revascularization were assessed prospectively. All patients underwent a CTP
scan of the lower leg, and hemodynamic and angiographic assessment. Hemodynamic
parameters, specifically ankle-brachial pressure index (ABI), ankle blood pressure (ABP),
peak systolic velocity (PSV), and segmental pulse oscillography (SPO) level, were deter-
mined. Lesion length and degree of collateralization were assessed by interventional angi-
ography. CTP parameters were calculated with a perfusion software, acting on a no outflow
assumption. A sequential two-compartment model was used. Differences in CTP parame-
ters and correlations between CTP, hemodynamic and angiographic parameters were
assessed with non-parametric tests.
Results
The cohort consisted of 27 subjects with an occlusion, and eight with a high-grade stenosis.
The mean blood flow (BF) was 7.71 ± 2.96 ml/100ml*min-1, mean blood volume (BV) 0.71 ±
0.33 ml/100ml, and mean mean transit time (MTT) 7.22 ± 2.66 s. BF and BV were higher in
subjects with longer lesions, and BV was higher in subjects with lower ABI. Significant corre-
lations were found between lesion length and BV (r = 0.65) and BF (r = 0.52). Significant
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inverse correlations were found between BV and ABI and between BV and ABP (r = -0.56,
for both correlations).
Conclusions
In our study, we have shown the feasibility of CTP for the assessment of PAD. In the future,
this quantitative method might serve as a non-invasive method, possibly complementing the
diagnostic workup of patients with peripheral arterial disease.
Introduction
Peripheral arterial disease (PAD) is one of the major cost-driving factors in public healthcare
[1]. Similar to coronary artery disease, it is associated with a history of smoking, diabetes,
hypertension, and hyperlipidaemia [2]. One of its predominant clinical substrates and early
indicators is pain in the lower extremities, which is caused by ischemia due to insufficient
blood flow to the dependent musculature [3]. This may be elicited chronically by progressive
luminal narrowing, or acutely by thromboembolic occlusion [4]. Historically, perfusion of the
soft tissues of the limbs has been assessed with scintigraphic methods, especially in patients
with diabetes [5–8]. Recently, efforts have been made to investigate PAD using computed
tomography (CT) angiography, contrast-enhanced magnetic resonance imaging (MRI), and
ultrasound (US) [9–11]. To date, there was only little interest in limb perfusion assessment by
volumetric CTP [12, 13]. Nevertheless, several potential advantages advocate an evaluation of
CT for this task. First, data acquisition by CT is much faster than by MRI, more robust and
easily standardizable [12]. Second, clinical CT provides a higher spatial resolution than MRI
[14]. Third, in contrast to MRI and US, CT allows for a comparably easy true quantitation of
perfusion, with contrast medium (CM) concentrations directly corresponding to attenuation
values [15]. Lastly, unlike US, CT is supposedly a non-operator dependant method. However,
there are some issues in CTP that need to be addressed. The simultaneous acquisition of large
volume data sets, being mandatory for limb assessment, is nowadays possible with a new gen-
eration of scanners with a larger Z-axis coverage [16]. Beam-hardening artefacts and streak
artefacts from adjacent osseous structures may be solved by proper tissue segmentation, vol-
ume of interest (VOI) restraints and post-processing algorithms [17]. Radiation exposure is
one of the drawbacks of CT imaging, in contrast to US or MRI. However, critical organ doses
are not reached with CT perfusion imaging [18]. Furthermore the radiation exposure from
perfusion imaging is lower in the extremities compared to chest or abdominal imaging. This is
also reflected by considerably different tissue weighting factors in ICRP publication 103 (skin
and bone: 0.01, compared to chest or stomach: 0.12) [19]. In contrast to the myocardium and
lungs, perfusion imaging of the limbs is less prone to organ motion during scan [20]. Never-
theless, involuntary movement may degrade data acquisition [21]. This is especially true for
symptomatic PAD patients suffering from pain. Therefore, the application of motion correc-
tion algorithms, as supplied by current processing software, seems to be mandatory [20, 22–
24]. Skeletal muscle is not as vascular as myocardium or solid organs such as the liver. Thus,
CT contrast enhancement in skeletal muscle is fainter than in these structures. In addition, the
venous outflow from skeletal muscles is difficult to assess.
Despite several potential benefits, such as fast and non-invasive quantitation of tissue ische-
mia, the clinical application of CTP of the limbs has so far been challenged by the aforemen-
tioned technical difficulties, and larger patient studies are still missing.
CT-perfusion in peripheral arterial disease
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Therefore, the purpose of our study was the assessment of volumetric CTP of the lower leg
musculature in patients with symptomatic PAD, and the comparison of CTP parameters with
state-of-the-art angiographic and hemodynamic parameters, in order to further characterize
the potential role of this non-invasive method for the quantitative in-vivo assessment of limb
ischemia.
Materials and methods
This prospective study was approved by the institutional review board and by the cantonal eth-
ics committee (Kantonale Ethikkommission Luzern). All patients provided informed signed
consent prior to the examinations. Thirty-five consecutive patients (median age 72 years,
range 48 to 87 years, 13 females, 22 males) with symptomatic PAD of the legs were evaluated.
All patients were referred for angioplasty for unilateral interventional revascularization of
arteries that provide blood supply to the lower leg. Symptomatic PAD was defined as preva-
lence of intermittent claudication, ischemic rest pain and ischemic tissue loss such as gangrene
or non-healing ischemic ulcers, and ultrasonographic evidence of a hemodynamically signifi-
cant obstruction of the common iliac, external iliac, superficial femoral or popliteal artery.
Medical history was recorded. Further details are given in S1 File.
All subjects underwent clinical assessment of hemodynamic parameters within 24 hours
prior to revascularization (see below). Angiographic parameters were assessed at the beginning
of the interventional revascularization. Immediately before the revascularization procedure, all
patients underwent a CTP scan of the lower leg.
Hemodynamic assessment
Hemodynamic assessment was performed in all patients prior to the planned revasculariza-
tion. Evidence of hemodynamically significant obstruction was established by non-invasive
vascular testing, pulse volume recordings and duplex ultrasound imaging studies.
For the assessment of the maximum ankle-brachial pressure index (ABI) and the systolic
ankle blood pressure (ABP; mmHg), patients were placed in supine position at rest for 5–10
minutes in a room with ambient temperature (22–25˚C). A digital oscillometric automatic
blood pressure device with appropriately sized blood pressure cuffs (HEM-907, Omron, Mat-
susaka, Japan) was used to measure systolic, diastolic and mean arterial blood pressure on
both upper arms simultaneously. Less than 12 mmHg inter-arm systolic pressure gradient was
regarded as normal [25]. The ABI was calculated by dividing the highest pressure of each leg
by the highest systolic arm pressure. Further details are given in S1 File. Arteries in subjects
with an ABI� 1.40 were considered incompressible. ABI and ABP values of these subjects
were not considered for further analysis, because such values indicate the presence of media
sclerosis. An ABI of 1.00 to 1.40 was considered as normal, borderline from 0.91 to 0.99, and
pathologic if < 0.91 [26]. The ABI was rated as mildly pathologic from 0.50 to 0.89, and
severely pathologic if < 0.49.
Segmental pulse oscillography (SPO) was performed with a two-channel device (Infraton
Boucke 3000, Fritac AG, Baden, Switzerland). For this study, only the pulse curves of the lower
calf were taken into account. Pulse curves were rated as normal if the wave morphology was
dichotomous, mildly pathologic with blunt wave morphology and absence of dichotomy, and
severely pathologic with flat waves. Maximum impairment of arterial perfusion in a given seg-
ment was characterized by a zero baseline. Ultrasonographic imaging was performed with a
clinical ultrasound system (IU 22, Philips, Best, The Netherlands). Clinical standard criteria
were applied to quantify the severity of a stenosis. In subjects with vessel stenosis, the ratios of
peak systolic velocity (PSV; m/s) in the stenotic segment and prestenotic PSV were calculated.
CT-perfusion in peripheral arterial disease
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CTP assessment
All CTP examinations were performed with a 128-slice CT scanner (Somatom Definition
Flash, Siemens Healthcare, Forchheim, Germany) in shuttle mode, allowing for 28.2 cm of
axial coverage and 2 s temporal resolution, which included almost all muscles of both lower
legs in every subject. After placement on the gantry table, the patients’ feet were fixated using
tape to prevent spontaneous movement. The tube current was set to 100 mAs, the tube voltage
to 100 kV(p). The duration of the CT-perfusion scan was 60 s, with a rotation time of 2 s. CTP
was started 15 s after injection of 60 ml of CM (Ultravist 370, Bayer Healthcare, Leverkusen,
Germany) at 5 ml/s. CM was injected into an antecubital vein by a dual-head pump injection
device (Stellant D, Medrad, Warrendale, USA), followed by a flush of 50 ml of NaCl at 5 ml/s.
The collimation was 64 x 0.6 mm. The reconstruction increment was 10 mm at 10 mm slice
width. Image reconstruction was performed with a 512 x 512 pixel matrix and medium smooth
B30f kernel. For image post-processing and analysis, the reconstructed images of both legs
were transferred to a commercially available computer workstation (Syngo Multimodality
Workplace, Siemens Healthcare, Erlangen, Germany).
CTP parameters blood flow (BF; ml/100ml � min-1), blood volume (BV; ml/100ml), and
mean transit time (MTT; s) were calculated with a perfusion software (Syngo Volume Perfu-
sion CT Body, Siemens Healthcare, Erlangen, Germany), based on the Patlak analysis. Since
veins did not show sufficient CM enhancement in the late phase of the dynamic series and
since venous enhancement was furthermore often degraded by pathologic flow within varicose
veins in our patient cohort, no outflow curve was obtained. Thus, as previously described in
the literature, we acted on a no outflow assumption [13, 27–29]. Dataset motion correction
and a noise reduction algorithm were applied automatically. Processing thresholds or segmen-
tation tissue limits were -50 HU and +150 HU to exclude bone, vessel wall calcification and
other hyperdense material. Window width and center for reference vessel input was +300 HU
and +150 HU, respectively. The relative threshold for inside and outside was 50%, an adaptive
smoothing filter was used. The vendor’s standard algorithmic parameters were applied. 3D
color-coded maps for BF, BV and MTT were generated with a sequential two-compartment
model. BF is defined as the amount of blood flowing through 100ml of muscle tissue within
one minute. MTT is defined as the average time of contrast agent residence within the muscle
tissue. BV is defined as the amount of blood within 100ml of muscle tissue. BV can be
expressed as proportion of the total volume of a dedicated voxel. For every patient, an individ-
ual arterial input fraction was determined by placing a region of interest (ROI) into the popli-
teal artery. A dedicated free-hand user-defined ROI was drawn around the calf muscles on
every slice and adapted to their confines. Adjacent bones, vessels, and other soft tissue struc-
tures were excluded. All image evaluations were performed by two experienced radiologists in
consensus with 8 and 12 years of experience.
Angiographic assessment
Before the start of revascularization, the length of the occlusion or stenosis was measured on
subtracted angiographic images (Allura Xper FD, Philips). The lesion length was rated as short
(1) if < 4 cm, medium (2) if 4–10 cm, and long (3) if > 10 cm. The degree of collateralization
was assessed by visual estimation on angiographic images. It was rated as good (1) if the esti-
mated cross-sectional area of collaterals added up to> 50% of the pre-lesion diameter of the
collateralized vessel, medium (2) if < 50%, and poor (3) if only faint or no collaterals were visi-
ble. The performing interventional radiologist had 20 years of experience in the field of revas-
cularization procedures.
CT-perfusion in peripheral arterial disease
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Statistical analysis
Demographic, hemodynamic, angiographic and CTP parameters in patients with stenosis and
occlusion were compared by Mann-Whitney U-test. Differences of CTP parameters between
symptomatic and non-symptomatic limbs were analysed by Wilcoxon signed ranks test. CTP
parameters were stratified by lesion length, collateralization, ABI and SPO, and were then
compared by Kruskal-Wallis test. The correlation between CTP, hemodynamic and angio-
graphic parameters was analysed using Spearman’s correlation. Results were interpreted as
almost perfect correlation between ±0.81 and ±1.00, substantial between ±0.61 and ±0.80,
moderate between ±0.41 and ±0.60, fair between ±0.21 and ±0.40, there under no correlation
[30]. A p-value of< 0.05 was considered statistically significant. All analyses were performed
using IBM SPSS Statistics 21.0.0 (SPSS Inc., Chicago, IL, USA).
Results
Patients and clinical parameters
Twenty-seven patients (77%) were referred for interventional revascularization of an occlu-
sion, eight patients (23%) for a high-grade stenosis. All lesions were located unilaterally in the
common iliac, external iliac or superficial femoral artery. Occluded vessel segments were sig-
nificantly longer than stenotic segments (Fig 1A), while the degree of collateralization in both
types of lesions was not significantly different. Patients with medium and long lesions had a
higher degree of collateralization than patients with short lesions, (p = 0.041) (S1 Table).
ABP values indicative of media sclerosis were found in 7 subjects (5 occlusions, 2 stenoses).
ABP and ABI values of these subjects were hence excluded from analysis. The majority of the
remaining patients had mildly pathologic ABI values (n = 22), five had severely pathologic val-
ues, and one a normal value. For a comparison of CTP parameters stratified by ABI, subjects
were assigned to three equally distributed groups (ABI� 0.70; 0.60–0.69;� 0.59).
PSV could not be determined in 6 subjects (5 occlusions, 1 stenosis). Upstream PSV was
significantly higher in stenotic than in occluded vessels. Detailed results are given in Table 1.
Absolute CTP values
The mean BF of the symptomatic limb was 7.71 ± 2.96 ml/100ml tissue � min-1, the mean BV
was 0.71 ± 0.33 ml/100ml tissue, and the mean MTT was 7.22 ± 2.66 seconds. Below we pro-
vide data of the asymptomatic limb as well, whenever statistical significance is claimed for CT-
parameters in the symptomatic limb, in order to identify potential inter-group differences
against intra-individual, inter-limb differences.
Comparison of CTP parameters in different subgroups
Overall, CTP parameters were neither significantly different in patients with stenosis or occlu-
sion, nor in the symptomatic and asymptomatic limb (Tables 1 and 2, Fig 1B). However, in
the subgroup with short lesions, higher CTP parameters were found in the asymptomatic than
in the symptomatic limb (Table 2).
BF and BV of the symptomatic leg were significantly different depending on lesion length,
with lowest values obtained in short lesions, and highest values in long lesions (Fig 1C). For
MTT no such difference was found.
CTP parameters were not different when stratified by the degree of collateralization
(Table 3).
There was no significant difference in CTP parameters when stratified by the SPO level.
CT-perfusion in peripheral arterial disease
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BV of the symptomatic limb was significantly different among ABI groups (p = 0.006), with
higher BV in patients with lower ABI (Fig 1D). In the asymptomatic limb, there was no signifi-
cant difference of BV among the ABI groups (p = 0.18).
Correlation of CTP parameters
A substantial correlation was found between BV and lesion length (r = 0.65, p< 0.001; Fig
2A), and a moderate correlation between BF and lesion length (r = 0.52, p = 0.001). BV showed
a moderate inverse correlation with ABI (Fig 2B) and ABP (r = -0.56, p = 0.002, each). Similar
correlations were obtained in the subgroup analysis of subjects with occlusions, although by
trend with lower coefficients (Table 4).
Discussion
Our study shows that semiquantitative CTP imaging of the lower limb is feasible. To our
knowledge, this is one of the earliest reports evaluating semiquantitative CTP values of the
lower leg in PAD patients. Our study analyses the correlation of CTP parameters with state-of-
the-art clinical parameters and with invasive angiographic assessment.
Fig 1. Box plots of CTP parameters and lesion length. (a) BF values in patients with occlusion (n = 27) and stenosis
(n = 8), p = 0.13. (b) Lesion length in patients with occlusion (n = 27) and stenosis (n = 8), p = 0.01. (c) BV values in
short (n = 10), medium (n = 13) and long lesions (n = 12), p = 0.001. (d) BV values in patients with high (n = 8),
medium (n = 9) and low (n = 10) ABI values. The upper edge of the box indicates the 75th percentile, the lower edge of
the box indicates the 25th percentile, the line within the box indicates the median, and the ends of the whiskers indicate
minimum and maximum values. Stars indicate outliers. BF: blood flow, BV: blood volume.
https://doi.org/10.1371/journal.pone.0223066.g001
CT-perfusion in peripheral arterial disease
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We could show that BF and BV are higher in subjects with longer lesions, and that BV is
higher in subjects with lower ABI. In the subgroup with short lesions, BF and BV were lower
compared to the asymptomatic limb. In our collective, patients with medium and long lesions
had significantly better collateralization than patients with short lesions. Furthermore, we
found a positive correlation between CTP parameters BF and BV and the lesion length, and an
inverse correlation between BV and ABI. No significant correlation was found between CTP
parameters and SPO or PSV.
The ABI is a well-established indicator for PAD, which is generally used for clinical evalua-
tion of symptomatic patients. Such was true in our study cohort as well, since only one of 28
patients (3.6%) without suspicion of media sclerosis had a normal ABI value [31]. However,
ABI is a global measure of perfusion and does not account for regional differences in the leg
[13]. Because treatment options in PAD patients are still limited, the ABI is not recommended
as a general screening test [32]. This might change in the future, since several new molecular
and regenerative therapeutic agents are under investigation [32, 33]. However, there is a basic
need for a method that provides reliable, reproducible, and observer-independent quantitative
assessment of extremity perfusion. Such a method ideally reflects the entire extent of disease,
and not only the morphological surrogate which is partly responsible for the acute symptoms
of patients. Furthermore, such a method should not be solely based upon the blood flow in the
largest vessels of the leg, which is the basic underlying physiologic parameter of the ABI. Being
able to provide better diagnostic overview would potentially allow to more accurately stratify
the collective of treatable patients, optimally with therapeutic options at hand in early disease
stages.
In patients with a pathologic ABI, further diagnostic tests are necessary in order to localize
lesions and assess the grade of stenosis. Several different modalities provide detailed character-
istics of the clinically relevant lesion. To date, invasive diagnostic tests are the first line recom-
mendation for patients eligible for revascularization [32]. However, the causative lesion
(stenosis or occlusion) and the acute symptoms do neither reflect the whole extent of the dis-
ease, the degree of functional (and not only morphological) collateralization, and the consecu-
tive compensatory mechanisms nor do they provide information on hypoxic downstream
tissue at risk. In our study, ABI values were even inversely correlated to the BV of downstream
musculature. Besides proximal vessel pathology, other factors such as chronic downstream
Table 1. Patient data.
Parameter All
(n = 35)
Occlusion
(n = 27)
Stenosis
(n = 8)
p-value
Age [y] (median (range)) 72 (48–87) 72 (48–87) 66 (48–85) 0.34
Length of lesion [cm] (mean ± SD) 9.6 ± 7.8 10.9 ± 7.8 5.1 ± 6.3 0.01
Degree of collateralization (median (range)) 2 (1–3) 2 (1–3) 2 (2–3) 0.29
ABI (mean ± SD) � 0.62 ± 0.15 0.60 ± 0.14 0.71 ± 0.18 0.19
ABP [mmHg] (mean ± SD) � 86.6 ± 38.0 79.9 ± 23.9 116.0 ± 71.3 0.49
SPO level (median (range)) 2 (1–3) 2 (1–3) 2 (1–3) 0.80
PSV [m/s] (mean ± SD) � 1.39 ± 1.74 0.89 ± 1.11 2.98 ± 2.45 0.02
BF [ml/100ml�min-1] (mean ± SD) 7.71 ± 2.96 8.14 ± 3.11 6.26 ± 1.85 0.13
BV [ml/100ml] (mean ± SD) 0.71 ± 0.33 0.77 ± 0.35 0.54 ± 0.16 0.07
MTT time [s] (mean ± SD) 7.22 ± 2.66 7.34 ± 2.94 6.80 ± 1.45 0.86
ABI: ankle-brachial pressure index, ABP: ankle blood pressure, BF: blood flow, BV: blood volume, MTT: mean transit time, PSV: peak systolic velocity, SD: standard
deviation, SPO: segmental pulse oscillography.
� ABI and ABP values available in 28 patients (22 occlusions, 6 stenoses), PSV values available in 29 patients (22 occlusions, 7 stenoses).
https://doi.org/10.1371/journal.pone.0223066.t001
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microvascular occlusion are limiting the lifetime of the dependent musculature as well. Such
was shown repeatedly in well investigated cardiovascular patients with coronary artery disease
and might be one of the reasons that coronary artery stents were yet not proven to decrease
the mortality. This fact has changed the diagnostic workup of coronary artery disease with
non-invasive test, including contrast-enhanced CT imaging, are a first-line recommendation
now, and it might change the work-up of PAD as well. The first reason is that the invasive
angiography bears an inherent risk of complications, although in peripheral arteries possible
complications might be manageable more easily compared to cardiac and CNS angiography.
Another reason is that the interventional angiography, as well as all other currently used
assessments such as ABI, ABP, SPO, and PSV does not account for microvascular disease in a
quantitative manner. Furthermore, these modalities hardly consider the collateralization of
vessels or neo-angiogenesis. On the other hand, CTP parameters were shown to reflect micro-
vessel density in tumours and might serve as a more throughout assessment tool of vascular
Table 2. CTP parameters of the symptomatic and of the asymptomatic limb.
CT-perfusion parameters Symptomatic limb Asymptomatic limb p-value
All lesions (n = 35) Blood flow [ml/100ml�min-1] (mean ± SD) 7.71 ± 2.96 7.75 ± 2.63 0.73
Blood volume [ml/100ml]
(mean ± SD)
0.71 ± 0.33 0.73 ± 0.28 0.77
Mean transit time [s]
(mean ± SD)
7.22 ± 2.66 7.37 ± 2.70 0.58
Short lesions
(n = 10)
Blood flow [ml/100ml�min-1] (mean ± SD) 5.89 ± 1.35 6.48 ± 1.53 0.05
Blood volume [ml/100ml]
(mean ± SD)
0.49 ± 0.09 0.63 ± 0.18 0.01
Mean transit time [s]
(mean ± SD)
6.19 ± 1.31 6.88 ± 1.77 0.02
Medium lesions
(n = 13)
Blood flow [ml/100ml�min-1] (mean ± SD) 7.11 ± 1.83 7.26 ± 2.29 0.86
Blood volume [ml/100ml]
(mean ± SD)
0.62 ± 0.13 0.64 ± 0.23 0.51
Mean transit time [s]
(mean ± SD)
7.16 ± 2.54 7.21 ± 2.62 0.35
Long lesions
(n = 12)
Blood flow [ml/100ml�min-1] (mean ± SD) 9.88 ± 3.66 9.35 ± 3.09 0.37
Blood volume [ml/100ml]
(mean ± SD)
1.00 ± 0.40 0.89 ± 0.32 0.16
Mean transit time [s]
(mean ± SD)
8.13 ± 3.40 7.94 ± 3.46 0.43
ABI�0.70
(n = 8)
Blood flow [ml/100ml�min-1] (mean ± SD) 7.05 ± 1.44 7.06 ± 1.55 0.89
Blood volume [ml/100ml]
(mean ± SD)
0.58 ± 0.08 0.67 ± 0.26 0.48
Mean transit time [s]
(mean ± SD)
6.71 ± 1.70 7.31 ± 2.07 0.12
ABI 0.60–0.69
(n = 9)
Blood flow [ml/100ml�min-1] (mean ± SD) 7.16 ± 2.52 8.05 ± 2.81 0.07
Blood volume [ml/100ml]
(mean ± SD)
0.58 ± 0.13 0.68 ± 0.19 0.24
Mean transit time [s]
(mean ± SD)
6.25 ± 2.00 6.33 ± 2.21 0.77
ABI�0.59
(n = 10)
Blood flow [ml/100ml�min-1] (mean ± SD) 9.27 ± 3.52 8.01 ± 2.64 0.42
Blood volume [ml/100ml]
(mean ± SD)
0.96 ± 0.35 0.88 ± 0.35 0.19
Mean transit time [s]
(mean ± SD)
8.46 ± 4.06 8.49 ± 4.07 0.96
SD: standard deviation.
https://doi.org/10.1371/journal.pone.0223066.t002
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disease compared to other modalities, including invasive tests [34]. This might open up the
way for early first line assessment of PAD and for response assessment to modern molecular
treatment options.
In a CTP study by Barfett et al., a significant difference of foot perfusion values between the
side of simulated vascular obstruction and the non-obstructed side were shown [13]. In our
study, this was true only in the subgroup of patients with short lesions, where BF and BV were
lower compared to the asymptomatic side. In the other patients, the pre-interventional CTP
values of the symptomatic limb were not significantly different to the asymptomatic side. The
reason might be that in longer lesions, the vascular bed has had more time to develop sufficient
collaterals. In line with this reason is the fact, that in our study BF and BV were higher in limbs
with long lesions, compared to those with short lesions, and that BV and BF correlated with
lesion length. This collateralization leads then to a successive diminution of the collateralized
vessel–until another acute event occurs, either proximal or distal to the collateralized segment,
Table 3. CTP parameters of the symptomatic limb, stratified by lesion length, degree of collateralization, SPO and ABI.
Groups n Blood flow [ml/100ml�min-1] (mean ± SD) p-value Blood volume [ml/100ml]
(mean ± SD)
p-value Mean transit time [s]
(mean ± SD)
p-value
Length of lesion
Short (<4cm) 10 5.89 ± 1.35 0.49 ± 0.09 6.19 ± 1.31
Medium (4-10cm) 13 7.11 ± 1.83 0.01 0.62 ± 0.13 0.001 7.16 ± 2.54 0.29
Long (>10cm) 12 9.88 ± 3.66 1.00 ± 0.40 8.13 ± 3.40
Degree of collateralization
Good 11 7.79 ± 2.33 0.74 ± 0.31 7.20 ± 2.75
Medium 17 7.54 ± 3.57 0.62 0.71 ± 0.36 0.79 7.55 ± 2.96 0.72
Poor 7 8.01 ± 2.53 0.70 ± 0.32 6.44 ± 1.74
SPO
Normal 4 9.11 ± 3.81 0.72 ± 0.40 5.90 ± 2.50
Mildly pathologic 20 9.37 ± 7.60 0.48 0.53 ± 0.72 0.70 6.24 ± 7.31 0.66
Severely pathologic 11 7.41 ± 3.80 0.64 ± 0.71 6.53 ± 7.53
ABI
�0.70 8 7.05 ± 1.44 0.58 ± 0.08 6.71 ± 1.70
0.60–0.69 9 7.16 ± 2.52 0.17 0.58 ± 0.13 0.006 6.25 ± 2.00 0.73
�0.59 10 9.27 ± 3.52 0.96 ± 0.35 8.46 ± 4.06
ABI: ankle-brachial pressure index, SD: standard deviation, SPO: segmental pulse oscillography.
https://doi.org/10.1371/journal.pone.0223066.t003
Fig 2. Scatter plots of BV and lesion length (A) and BV and ABI (B). ABI: ankle-brachial pressure index, BV: blood
volume.
https://doi.org/10.1371/journal.pone.0223066.g002
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Table 4. Spearman’s correlation coefficients (r) of CTP parameters (symptomatic limb), angiographic parameters and hemodynamic parameters in all patients
(n = 35) and in the occlusion group (n = 27).
Parameters Blood flow Blood volume Mean transit time
r p-value r p-value r p-value
All patients
Lesion length (n = 35) 0.52 0.001 0.65 0.000 0.28 0.10
Degree of collateralization (n = 35) -0.001 1.00 -0.11 0.54 -0.05 0.80
ABI (n = 28) -0.34 0.08 -0.56 0.002 -0.12 0.55
ABP (n = 28) -0.22 0.26 -0.56 0.002 -0.28 0.15
SPO (n = 35) -0.21 0.23 -0.08 0.65 0.13 0.44
PSV (n = 29) -0.06 0.75 0.05 0.79 0.14 0.46
Occlusion group
Lesion length (n = 27) 0.47 0.01 0.58 0.002 0.32 0.10
Degree of collateralization (n = 27) 0.01 0.95 -0.07 0.74 -0.05 0.81
ABI (n = 22) 0.32 0.15 -0.56 0.007 -0.20 0.38
ABP (n = 22) -0.24 0.28 -0.58 0.005 -0.30 0.18
SPO (n = 27) -0.18 0.37 0.01 0.98 0.20 0.22
PSV (n = 22) 0.06 0.80 0.25 0.26 0.22 0.33
ABI: ankle-brachial pressure index, ABP: ankle blood pressure, PSV: peak systolic velocity, SPO: segmental pulse oscillography.
No significant correlation was found between CTP parameters and the degree of collateralization, SPO and PSV. A patient with occlusion of the right-sided superficial
femoral artery is shown in Fig 3.
https://doi.org/10.1371/journal.pone.0223066.t004
Fig 3. Occlusion of the right-sided superficial femoral artery of a 72-year-old patient. Coronal digital subtraction
angiography image (A) shows a complete intermediate-length occlusion (arrows) of the right right-sided superficial
femoral artery, which is extensively collateralized (asterisks). The distal segment of the vessel is patent, however, with
caliber irregularities (arrowheads). CTP of the lower leg (B, maximum intensity projection CT image during 60s after
contrast administration) with color-coded parametric maps (C-E) reveals a mean blood flow of 5.54 ml/100ml�min-1
(C), mean blood volume of 0.81 ml/100ml (D) and mean transit time of 12.85 s (E).
https://doi.org/10.1371/journal.pone.0223066.g003
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which then overburdens the collateral capacity. This factor was not studied by Barfett et al.,
since their study was performed in healthy subjects. With regard to our results (BF and BV dif-
ferences in symptomatic and asymptomatic limbs, less collaterals with short lesions), CTP
might be particularly useful in patients with short lesions (or early PAD) where there is a rela-
tive lack of collateralization.
Since PAD is considered a generalized disease, changes of the microvascular density might
alter the vascular supply of the muscles significantly on both the symptomatic and the asymp-
tomatic side. On one hand, the microvascular occlusion might reduce the perfusion of the
muscles. On the other hand, it has been shown that in limbs with a severe stenosis, ischemia
induces neo-angiogenesis [35]. This may be reflected in higher than expected perfusion values
in a limb with a hemodynamically relevant stenosis compared to the other side, where only
microvascular disease is found. Another possible reason for the similar CTP values of symp-
tomatic and asymptomatic limb in our patients with long lesions might be that the scans were
acquired during a rest situation. Such is well known from myocardial perfusion examinations,
where ischemic myocardium typically appears normal at rest. Stress conditions, which are
known to provoke clinical PAD symptoms, were not simulated in our study. Due to disease-
specific alterations of the vessel wall, e.g. calcifications, the consecutive lack of elasticity might
prevent the vessels from physiologic contraction under rest situations. This should be investi-
gated in future studies comparing the perfusion at rest and during stress, in order to compare
the “functional flow reserve” of symptomatic and asymptomatic limbs.
The assessment of CT perfusion in calf muscles, as performed in our study, might have
advantages over the perfusion measurement in the skin or muscles of the foot. We expect per-
fusion values obtained in muscle tissue be more reliable compared to skin-derived values,
since they are more independent of ambient temperature and resistant to movement artefacts
if patients are positioned properly [12, 13, 16]. However, further studies on state-of-the-art
scanners are necessary to compare perfusion measurements at different levels of the leg intra-
individually. Recapitulating our results, we have shown that CTP values obtained in calf mus-
culature, which represents the anatomic substrate for the clinical hallmark of critical limb
ischemia, i.e. claudication, might reflect an appropriate overview of the local (limb related)
PAD. CTP takes into account the functional collateralization and physiological compensation
mechanisms of the body. It might therefore be an appropriate tool for PAD patients, comple-
menting the diagnostic workup. Furthermore, CTP scans with a larger craniocaudal field-of-
view may cover the majority of the leg, and when comparing perfusion values at different levels
might help predict the appropriate level for intervention with regard to the emerging concept
of angiosome-specific treatment [34–36].
Besides stenosis diameter and length, BF is also determined by partly microscopic parame-
ters that are more difficult to quantify exactly, such as microvascular obstruction and collatera-
lization. Our study cannot identify which one of these parameters is the dominant factor
determining BF. This might be the reason for not finding a strong correlation between CTP
and different parameters.
It should be mentioned that our study has some limitations. We did perform consensus
reading instead interreader evaluation of results [37]. There are several software with different
underlying calculation models available and evaluation of the reading performance with differ-
ent software/models was beyond the scope of our initial evaluation [38, 39]. Also, we do not
provide CTP values of a collective of healthy subjects for comparison. While this is a major
drawback, it is ethically hard to justify obtaining CTP data from healthy volunteers. Those
would have to be age-matched, too (and any elderly patient might not be considered as “vascu-
lar healthy” anymore). Such healthy volunteer scanning might be justifiable in large patient
collectives, however not necessarily in an initial evaluation like ours.
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Asymptomatic limbs in our cohort are inherent parts of the systemic disease as well, and as
shown in our study, cannot serve as standard of reference for absolute CTP values. Future
work might analyse CTP parameters in patients with critical limb ischemia at rest and at stress,
and before and after revascularization. Also, we did not compare CTP with other quantifiable
perfusion imaging, such as PET perfusion. Although an accurate technique, it is only available
in a few centers worldwide, owing to financial, technical and logistic issues [40, 41]. Finally,
CTP parameters were overall not significantly different in the symptomatic and asymptomatic
limb. The main reason is probably that our study was acquired at rest, not at stress. Another
reason might be the relatively small sample size. Furthermore, since PAD is considered a gen-
eralized disease, changes of the microvascular density might alter the vascular supply of the
muscles significantly in both the symptomatic and the asymptomatic side. On one hand, the
microvascular occlusion might reduce the perfusion of the muscles. On the other hand, it has
been shown that in limbs with a severe stenosis (and subsequent hypoxia), ischemia induces
neoangiogenesis.
Overall, since there was a difference in CTP parameters in patients with short stenosis, one
possible explanation might be that using CTP-values in direct intra-individual comparison in
this indication works best in a specific time window (e.g. after initial/early vessel narrowing).
Conclusions
In our study we showed that BF and BV are higher in subjects with longer lesions and that BV
is higher in subjects with lower ABI. In a subgroup with short lesions, BF and BV were lower
compared to the asymptomatic limb. Furthermore, we found a positive correlation between
CTP parameters BF and BV and the lesion length, and an inverse correlation between BV and
ABI. In the future, this quantitative method might serve as a non-invasive method, which
might complement the diagnostic workup of patients with peripheral arterial disease.
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